Our Services
Stern IR offers a broad range of investor relations services that often includes working with senior management to achieve key investor relations goals, such as effective positioning, enhancing visibility, improving institutional ownership and sell-side coverage, preparing for financings and IPOs, developing good guidance practices and managing communications around M&A, binary events and other strategic issues.
Since our inception, we have worked with more than 200 companies in the industry, and we represent public and private companies in all stages of development and in a wide range of clinical indications. The firm is based in New York City.
Our Approach
Our ultimate goal is to help each client realize a valuation that best reflects the company's assets and the internal value of the company through favorable interactions with the investment community.
Our Clients
- Acceleron Pharma, Inc.
- Acorda Therapeutics Inc.
- Alnylam Pharmaceuticals, Inc.
- AMAG Pharmaceuticals, Inc.
- Archemix Corp.
- BioSpecifics Technologies Corp.
- Curis, Inc.
- Interleukin Genetics, Inc.
- ImmunoGen, Inc.
- Ironwood Pharmaceuticals, Inc.
- Lux Biosciences, Inc.
- Millennium: The Takeda Oncology Company
